×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

Three Drug Development Habits to Mitigate Commercial Risk

August 22, 2017

In today’s cost-constrained healthcare markets, winning payer reimbursement for newly approved products has become increasingly challenging. And even if a drug wins reimbursement, there are no guarantees it will succeed in the market.

However promising a product might appear, if you do not have the right evidence early on (or if you fail to recognize that the data you do have are no longer relevant to key stakeholders), risks may actually be rising as market launch nears. 

Commercial risk is so multifaceted that developers need a multifaceted strategy to cope with it, incorporating evidence generation, gated reviews and market analysis. While this will require more work, the return on the investment is high.

Previous Flipbook
Real-World Data Strategies
Real-World Data Strategies

Find out what payers are most concerned about in this article!

Next Flipbook
Commercialization_Strategy_Willingness_To_Pay_PDF_Casestudy_250215
Commercialization_Strategy_Willingness_To_Pay_PDF_Casestudy_250215